244 related articles for article (PubMed ID: 9620778)
1. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
Kolquist KA; Ellisen LW; Counter CM; Meyerson M; Tan LK; Weinberg RA; Haber DA; Gerald WL
Nat Genet; 1998 Jun; 19(2):182-6. PubMed ID: 9620778
[TBL] [Abstract][Full Text] [Related]
2. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
3. Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Zhang L; Zhang W
Chin J Dent Res; 1999 May; 2(2):43-8. PubMed ID: 10863406
[TBL] [Abstract][Full Text] [Related]
4. Severe growth defect in mouse cells lacking the telomerase RNA component.
Niida H; Matsumoto T; Satoh H; Shiwa M; Tokutake Y; Furuichi Y; Shinkai Y
Nat Genet; 1998 Jun; 19(2):203-6. PubMed ID: 9620783
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
7. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.
Greenberg RA; Allsopp RC; Chin L; Morin GB; DePinho RA
Oncogene; 1998 Apr; 16(13):1723-30. PubMed ID: 9582020
[TBL] [Abstract][Full Text] [Related]
8. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.
Counter CM; Meyerson M; Eaton EN; Ellisen LW; Caddle SD; Haber DA; Weinberg RA
Oncogene; 1998 Mar; 16(9):1217-22. PubMed ID: 9528864
[TBL] [Abstract][Full Text] [Related]
11. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
12. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
[TBL] [Abstract][Full Text] [Related]
13. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
15. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
[TBL] [Abstract][Full Text] [Related]
16. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
17. Telomerase reactivation is an early event in laryngeal carcinogenesis.
Luzar B; Poljak M; Marin IJ; Gale N
Mod Pathol; 2003 Sep; 16(9):841-8. PubMed ID: 13679446
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Ikeda S; Shibata T; Funakoshi N
Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
[TBL] [Abstract][Full Text] [Related]
19. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
[TBL] [Abstract][Full Text] [Related]
20. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
